European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 129 citations · 36 references
MedicineCancer BiologyOncologyImmunotherapyMolecular ImagingTheranosticsCancer BiomarkersCancer ImmunotherapyCheckpoint Inhibitor TherapyImmune Checkpoint InhibitorsImmune Checkpoint RegulationImmuno-oncology BiomarkersImmune Checkpoint Inhibitor BiomarkersImmunotherapy BiomarkersMelanoma BiomarkersMelanoma ImmunotherapyProgrammed Death-ligand 1 BiomarkerProgrammed Death-ligand 1 InhibitionTheranostic Imaging Biomarkers
36
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Rosandra N. Kaplan, Rebecca D. Riba, Stergios Zacharoulis et al. · Nature · 2005 · 3.2K citations · Full text
Medicine, Cell Biology, Hematology +14
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard et al. · Cell · 2018 · 2K citations · Full text
Life Sciences, Immunology, Oncology +14